Original SARS-CoV-2 monovalent and Omicron BA.4/BA.5 bivalent COVID-19 mRNA vaccines: phase 2/3 trial interim results
原始 SARS-CoV-2 单价疫苗和 Omicron BA.4/BA.5 双价 COVID-19 mRNA 疫苗:第 2/3 期试验中期结果
期刊:Nature Medicine
影响因子:58.7
doi:10.1038/s41591-023-02517-y
Spyros Chalkias, Jordan L Whatley, Frank Eder, Brandon Essink, Shishir Khetan, Paul Bradley, Adam Brosz, Nichole McGhee, Joanne E Tomassini, Xing Chen, Xiaoping Zhao, Andrea Sutherland, Xiaoying Shen, Bethany Girard, Darin K Edwards, Jing Feng, Honghong Zhou, Stephen Walsh, David C Montefiori, Linds
代谢
免疫
心血管
新冠
MSD
Human
SARS-CoV-2